Ensol Biosciences (XKRX:140610) Change In Inventory : ₩-23 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ensol Biosciences Change In Inventory?

Ensol Biosciences's change in inventory for the quarter that ended in Dec. 2024 was ₩-23 Mil. It means Ensol Biosciences's inventory increased by ₩23 Mil from Dec. 2023 to Dec. 2024 .

Ensol Biosciences's change in inventory for the fiscal year that ended in Dec. 2024 was ₩-23 Mil. It means Ensol Biosciences's inventory increased by ₩23 Mil from Dec. 2023 to Dec. 2024 .

Ensol Biosciences's Total Inventories for the quarter that ended in Dec. 2024 was ₩23 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Ensol Biosciences's Days Inventory for the quarter that ended in Dec. 2024 was 176.93.

Inventory Turnover measures how fast the company turns over its inventory within a year. Ensol Biosciences's Inventory Turnover for the quarter that ended in Dec. 2024 was 1.03.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Ensol Biosciences's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.01.

Ensol Biosciences Change In Inventory Historical Data

The historical data trend for Ensol Biosciences's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ensol Biosciences Change In Inventory Chart

Ensol Biosciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

-142.50

-202.26

46.36

-10.89

-23.22

Ensol Biosciences Semi-Annual Data
	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Change In Inventory	Get a 7-Day Free Trial						-142.50	-202.26	46.36	-10.89	-23.22

Ensol Biosciences Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-23 Mil.

Ensol Biosciences (XKRX:140610) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Ensol Biosciences's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	11.6095	/	11.975	*	365 / 2
	=	176.93

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Ensol Biosciences's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	11.975	/	11.6095
	=	1.03

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Ensol Biosciences's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	11.6095	/	1434.621
	=	0.01

Ensol Biosciences Change In Inventory Related Terms

Thank you for viewing the detailed overview of Ensol Biosciences's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Ensol Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ensol Biosciences Inc (XKRX:140610) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

51, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34036

Website

http://www.ensolbio.co.kr

Ensol Biosciences Inc is a Korean big data-driven biopharmaceutical company. The company is engaged in developing drugs for the diseases that have no therapeutic alternatives, such as a degenerative disc, osteoarthritis, cancer, Alzheimer's dementia, and type 1 diabetes. Its drugs portfolio includes Peniel 2000 Drug for Degenerative Disc Disease, Engedi 1000 Drug for Osteoarthritis, Charis 1000 Drug for Immuno-Oncology, Moriah 1000 Drug for Alzheimer's Disease, Shiloah 1000 Drug for Type I Diabetes, and EAD100 Drug for Animal Osteoarthritis.

Ensol Biosciences Headlines

No Headlines